SCHEMBL21899802

SCHEMBL21899802

CC/C(=C/CCO)CN(C)C

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5460596 0.80
SCHEMBL6709749 0.75
SCHEMBL11552377 0.67 SQLE (0.52) MAPT
SCHEMBL11552375 0.67 SQLE (0.52) MAPT
SCHEMBL23754414 0.65 LMNA (0.42) MAPT
SCHEMBL23754413 0.65 LMNA (0.42) MAPT
SCHEMBL23131744 0.64
SCHEMBL14103163 0.64 BACE1 (0.41)
SCHEMBL8024774 0.63
SCHEMBL11592900 0.62

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020081636-A1 INDOLE AHR INHIBITORS AND USES THEREOF Ikena Oncology, Inc. (US) 2020-04-23 WO disclosed